MDMA has just been approved for study by the DEA. In the study, researchers hope to find the medical benefits of using MDMA for anxiety and stress disorders in terminally ill patients. This is showing a new change in the thought process of the DEA. And possibly bringing MDMA one step closer to not being a Schedule I controlled substance.